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Abstract
Background: Typhae Pollen (TP) and Trogopterus Feces (TF) are well-known traditional medicine in china which
widely used for thousands of years as drug pair called Shixiao San for treatment of blood stasis syndrome, specially
shown great efficacy in gynecological disease. Typhaneoside, vanillic acid and p-coumaric acid are the main
bioactive components of Typhae Pollen. This study was carried out for comparing the pharmacokinetic profile of
these three major bioactive components in rats after oral administration of Typhae Pollen-Trogopterus Feces
(TP-TF) drug pair before and after compatibility.
Methods: A sensitive and rapid UPLC-TQ/MS method has been developed for simultaneous quantification of the
three main bioactive compounds in blood at different time points after oral administration of Typhae Pollen (TP)
and the combination with Trogopterus Feces (TF).
Results: There were significant differences of Cmax, Tmax, T1/2 and AUC0~t for three bioactive compounds among
the groups, for typhaneoside with the most highest plasma concentration of 370.86 ± 315.71 ng/mL and more
longer Tmax in TP-TF co-decoction group (CM); for vanillic acid, TP-TF co-decoction group (CM) had a good
absorption with Cmax (3870.99 ± 2527.99 ng/mL) and Tmax (1.47 ± 3.20 h); for p-coumaric acid, it had similar
pharmacokinetic characteristics with vanillic acid.
Conclusions: The three bioactive components in Typhae Pollen (TP) were simultaneously determined by UPLC-TQ/
MS and had a good absorption in rat plasma after the combination with Trogopterus Feces (TF).
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Background
Blood stasis (BS) is considered as a familiar type of clin-
ical symptoms and signs in Traditional Chinese Medi-
cine (TCM) for thousands of years, which is the
underlying pathology of many disease processes accord-
ing to TCM theory. Generally speaking, Blood stasis
(BS) refers to retarded blood flow and it is often associ-
ated with disruption of heart Qi (vital energy), thus giv-
ing rise to a series of hematological disorders such as
congestion, hemorrhage, thrombosis, local ischemia
(microclots) and even tissue changes [1, 2]. It mainly
manifested as pain, lassitude, bleeding, chills and fever,
bruise, muscle tension, and some dark blue signs like
black rim of eyes [3], women’s blood stasis mostly for
gynecology diseases for instance of dysmenorrhea,
menoxenia, uterine fibroids in clinic [4].
The drug pair of Typhae Pollen and Trogopterus Feces
which we named it for Shixiao San originally came from
the Classified Materia Medica in volume twenty-two jin-
xiao fang, which was written by Shen-wei Tang in Song
dynasty of ancient china [5]. As described in early publi-
cations, Typhae Pollen-Trogopterus Feces drug pair is
famous for its remarkable and reliable therapeutic ac-
tions in a multitude diseases caused by blood stasis such
as hyperlipidemia, atherosclerosis, thrombosis, stroke,
angina pectoris and gynecological diseases by means of
promoting blood circulation and removing stasis [6–8].
Typhae Pollen, known as Puhuang in Chinese is the dry
pollen of typhaceae plant Typha angustifolia L., Typha
orientalis Presl., and all species of the genus Typha [9].
Recent pharmacological study indicated that Typhae
Pollen is proved to possess quite a few of biological activ-
ities including inducing uterine contractions, antioxidant,
anti-inflammation, wound healing, and etc. [10–12],
which owes to the main active ingredients among them
like flavonoids, steroids, fatty acids, etc. [13]. Typhaneo-
side, vanillic acid and p-coumaric acid are just the three
major bioactive components consist in Typhae Pollen due
to their high content and significant bioactivities. Trogop-
terus feces also called Wulingzhi originally recorded in
the Kaibao Bencao, and it is the dry feces of Trogopterus
xanthipes Milne-Edwards (Petauristidae) [14]. It has been
reported that the main chemical constituents including
terpenoids [15], phenolic acids, sterols, aliphatics, fatty
acids, and flavonoids are commonly used in the inhibition
of tumor formation, inducing tumor cell apoptosis, anti-
oxidant, reducing antithrombin levels, cytotoxic activity,
immunity enhancement, anti-inflammatory activities, etc.
[16, 17].
Drug pair, as is less known at abroad, it is the unique
combination of two relatively fixed drugs based on the-
ory of TCM in clinic, which nowadays have played a key
role increasingly in the development of TCM and cap-
tured researcher’s attention for the most fundamental
and the simplest form of Chinese drug formulae [18,
19]. As the basic composition units of Chinese drug
compatibility, reducing the toxicity and increasing the
efficacy of drugs are supposed to be the basis of its effi-
ciency [20]. With an increasing number of researches on
drug pairs, works about the possible modes of actions
for some famous pairs have obtained a certain achieve-
ment, just like Danggui Buxue Decoction (Astragali
Radix and Angelicae sinensis Radix) [21] and Taoren-
Honghua (Persicae Semen and Carthami Flos) herb pair
[22]. More recent study suggested that how the synergis-
tic effects of drug pairs come into being not only by
changing the constitution or content of bioactive com-
pounds but also regulating its absorption, distribution,
metabolism and excretion (ADME) [23, 24].
According to the previous report, there are numerous
studies about Typhae Pollen-Trogopterus Feces drug pair
in each aspect while hardly any about the compatibility
mechanism of it. Here, based on our early investigations
[25, 26], the ultra-performance liquid chromatography
coupled with a triple quadrupole electrospray tandem
mass spectrometry (UPLC-TQ/MS) method has been per-
formed to compare the pharmacokinetic profile of three
major bioactive components including typhaneoside,
vanillic acid and p-coumaric acid among Typhae Pollen-
Trogopterus Feces drug pair before and after compatibil-
ity. Achievements of this study were desired to provide
beneficial scientific information for revealing the reason-
able compatibility of this drug pair and better understand-
ing about its in vivo behavior mechanism.
Methods
Chemicals, reagents and materials
The reference standards of typhaneoside (111573–
200603), vanillic acid (110776–200602), p-coumaric acid
(D-032-120603) and diphenhydramine hydrochloride as
internal standards (IS, 130356–200503) were purchased
from the National Institute for the Control of Pharma-
ceutical and Biological Products (Beijing, China), the
chemical structures of them are showed in Fig. 1.
Acetonitrile and methanol were of HPLC grade and
obtained from Jiangsu Hanbon Science and Technology
Co., Ltd. (China) and Tedia (Fairfield, USA), respectively.
Formic acid was analytical grade from Merck (Darm-
stadt, Germany). Ultra-pure water was purified by an
EPED super purification system (China). All other re-
agents were of analytical grade.
Typhae Pollen and Trogopterus Feces were purchased
from Nanjing Chinese and Western Pharmaceutical Co.,
Ltd., and authenticated by the corresponding author.
They were within the qualitative and quantitative stipu-
lation of Chinese Pharmacopoeia. The voucher speci-
mens (No.NJUTCM-20090118 for Typhae Pollen and
No.NJUTCM-20090119 for Trogopterus Feces) were
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deposited at the herbarium in Nanjing University of
Chinese Medicine, China.
Apparatus and UPLC-TQ/MS conditions
ACQUITYTM UPLC system, XevoTM TQ mass spec-
trometry system (Waters Corp., Milford, MA, USA);
EPED ultrapure water machine (Nanjing, China); Sartorius
BT1250 electronic balance (Sartorius Scientific Instru-
ments Corporation, Beijing, China); CENTRIVAP centri-
fuge enrichment apparatus (Labconco); ML303 electronic
balance (Mettler Toledo Instruments Co., Ltd. Shanghai,
China); TDL-80-2B centrifuge (Beckman Coulter, Inc.).
An ACQUITY UPLC BEH C18 column (2.1 mm×
100 mm, 1.7 μm, Waters Corp., Milford, MA, USA) was
applied and the column temperature was maintained at
35 °C. The mobile phase was composed of A (0.1 % aque-
ous formic acid) and B (acetonitrile) using a gradient elu-
tion of 5–10 % B at 0–1 min, 10–30 % B at 1–6 min, 30–
40 % B at 6–7 min, 40–95 % B at 7–8 min, 95–5 % B at
8–9 min, 95 % B at 9–10 min with a flow rate set at
0.4 mL/min. The auto-sampler was conditioned at 4 °C
and the injection volume was 5 μL.
Mass spectrometry detection was performed by using
a Xevo Triple Quadrupole MS (Waters Corp., Milford,
MA) equipped with an electrospray ionization source
(ESI). The ESI source was set in positive ionization
mode. The scanning mode was set multiple reaction
monitoring (MRM) mode. Parameters set in the source
were as follows: the capillary voltage at 1 kV; sampling
cone voltage of 30 V; source temperature 15 °C; desolva-
tion temperature 550 °C; dwell time was automatically
set by MassLynx (Waters Corp., Milford, MA, USA).
The cone voltage and collision energy optimized for
each analyte and selected values are given in Table 1.
Preparation of calibration standards and quality control
(QC) samples
The mixture of standard stock solution containing above
three compounds were prepared in methanol and giving
a final concentrations of 28.2 μg/mL for typhaneoside,
25.7 μg/mL for vanillic acid, and 26.5 μg/mL for p-cou-
maric acid, respectively. The mixture stock solution was
serially diluted with methanol to provide working
standard solutions of desired concentration of
0.282 mg/mL for typhaneoside, 0.257 mg/mL for
vanillic acid, and 0.265 mg/mL for p-coumaric acid,
respectively. The IS stock solution were also pre-
pared in methanol for diphenhydramine hydrochlor-
ide (IS) of 1.04 μg/mL.
Calibration standards and quality control (QC) sam-
ples were prepared as following: the mixture of standard
working solution was diluted into eight different concen-
tration gradients, and given the final concentration of
0.142 ~ 7100 ng/mL for typhaneoside, 0.104 ~ 5200 ng/
mL for vanillic acid, 0.102 ~ 5100 ng/mL for p-coumaric
acid. Quality control (QC) samples at low, middle and
high concentrations were 3.55, 71.0, 710 ng/mL for
typhaneoside, 2.60, 52.0, 260 ng/mL for vanillic acid and
2.55, 51.0, 255 ng/mL for p-coumaric acid. All solutions
were stored at 4 °C and brought to room temperature
before use. QC samples were stored at −20 °C before
analysis.
Preparation of drug extraction and sample solutions
The raw materials of Typhae Pollen (200 g) for single
extract and Typhae Pollen–Trogopterus Feces (200 g +
200 g) for co-decoction (two drugs decoct together) and
mixed decoction (two drugs decoct separately and then
mix) was accurately weighed, extracted with boiling
Fig. 1 Chemical structures of the reference substances (A. typhaneoside; B. vanillic acid; C. p-coumaric acid)
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water (1:10) for 2 h, and then extracted with boiling
water (1:8) for 2 h. The filtrates were combined and
solvent was removed under reduced pressure in a rotary
evaporator to reach a certain volume at the ratio of 1:1
(w/w, weight of all constituting drugs and the extract fil-
trates) for the TP single drug extraction; 2:1 for the TP-
TF co-decoction and TP-TF mixed decoction. The
contents of three compounds measured quantitatively
by UPLC were 167.73, 168.37, 153.32 μg/mL for
typhaneoside; 51.83, 48.67, 45.02 μg/mL for vanillic
acid and 36.62, 35.67, 33.12 μg/mL for p-coumaric
acid in single extract, co-decoction and mixed decoc-
tion, respectively.
A 200 μL aliquot of plasma sample was added with
10 μL diphenhydramine hydrochloride working solution
and 600 μL of methanol. After vortex for 2 min and cen-
trifugation at 13,000 rpm for 10 min, the supernatant
was transferred to another 1.5 mL tube and concen-
trated in the centrifuge enrichment apparatus at 37 °C.
Finally, each residue was reconstituted in 200 μL 70 %
methanol, then vortexed for 3 min and centrifuged at
13,000 rpm for 10 min. 5 μL of supernatant was injected
into the UPLC-TQ/MS system for analysis.
Validation of the HPLC method
Specificity, linearity and LLOQ
The specificity of the method was evaluated by comparing
chromatograms of blank plasma sample, blank plasma
sample spiked with reference standards and internal stan-
dards, and plasma sample after oral administration of
Typhae Pollen-Trogopterus Feces co-decoction for 30 min.
The linearity of each calibration curve was determined by
plotting the peak area ratio (Y) of analytes to corresponding
IS versus the nominal concentration (X) of analytes with
weighted (1/X2) least square linear regression. The lower
limit of quantification (LLOQ) was determined as the low-
est concentration with a signal-to-noise (S/N) ratio of 10.
Precision and accuracy
Accuracy and intra- and inter-day precision of the estab-
lished method were evaluated by QC samples at low,
medium and high concentrations (six samples for each)
Table 1 The optimum mass spectrometry conditions for three compounds and IS
Analytes Ionizationmode MRM transitions (precursor-product) Cone voltage
(V)
Collision energy (eV)
Typhaneoside ES+ 771.0319→ 317.0719 18 26
Vanillic Acid ES+ 168.8404→ 65.1300 16 20
P-coumaric Acid ES+ 164.8404→ 91.0910 16 26
Diphenhydramine Hydrochloride ES+ 256.2127→ 167.1291 12 16
Fig. 2 Representative MRM chromatograms of the three components in rats: A. blank plasma. B. blank plasma samples spiked with reference
standards and internal standards. C. plasma sample after oral administration of Typhae Pollen- Trogopterus Feces co-decoction for 30 min. Note:
a. typhaneoside; b. vanillic acid;c. p-coumaric acid; d. diphenhydramine hydrochloride
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on 3 consecutive validation days. The precision expressed
by relative standard deviation (RSD%), and the accuracy
by relative percentage error (%).
Extraction recovery, matrix effect and stability
The extraction recoveries of analytes were determined
by comparing the peak responses of three QC samples
(six samples for each) in the post-extraction spiked sam-
ples to that acquired from pre-extraction spiked samples
at equivalent concentrations. The matrix effect was eval-
uated by comparing the peak responses of samples
where the extracted matrix was spiked with standard so-
lutions to those obtained from neat standard solutions
at equivalent concentrations.
The stability of the analytes in rat plasma was assessed
by analyzing QC samples at three concentration levels
(six samples for each) under different condition. Three
QC samples were tested for pre-treatment, post-
treatment and three freeze-thaw cycles at room
temperature for 12 h, refrigerated (4 °C) for 24 h and re-
peatedly frozen and thawed for three times at −80 °C,
respectively.
Pharmacokinetic studies
All experiments were performed on female Sprague–
Dawley (SD) rats, weighing 220–250 g, obtained from
Shanghai Slac Laboratory Animal Co., Ltd. (Shanghai,
China). They were kept in plastic cages at 22 ± 2 °C and
a relative humidity of 50–65 %, with free access to pellet
food and water on a 12 h light/dark cycle. Animal wel-
fare and experimental procedures strictly conformed to
the Guide for the Care and Use of Laboratory Animals
[27] and the related ethics regulations of Nanjing Uni-
versity of Chinese Medicine.
For pharmacokinetic studies, the SD rats were divided
into four groups randomly (n = 6 per group), and housed
with unlimited access to food before the experiment
while water available. Each group except the control
group was oral administration of TP (CN) single drug
decoction, TP-TF co-decoction (CM) and TP-TF mixed
decoction (CB) at a dosage of 5 g/kg, 10 g/kg, 10 g/kg
body weight, respectively. Blood samples (0.5 mL) were
collected at certain time points and placed at a 1.5 mL
tube before oral (0 min) and after oral (5, 15, 30, 45, 60,
120, 240, 360, 480, 720 and 1440 min) administration.
Afterwards all the blood samples were centrifuged at
Fig. 3 Mean plasma concentration-time curves of three compounds after oral administration with TP (CN), TP-TF co-decoction (CM) and TP-TF
mixed decoction (CB) (n = 6)
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13,000 rpm for 10 min and stored at −80 °C until
analysis.
Results and discussion
Validation of the quantitative analysis
Fig. 2 shows the typical MRM chromatograms of blank
plasma sample, blank plasma sample spiked with refer-
ence standards and internal standards, and plasma sam-
ple after oral administration of Typhae Pollen-
Trogopterus Feces co-decoction for 30 min. No interfer-
ence peaks were observed at the retention times of ana-
lytes and IS in any plasma that used for analysis, the
method presented good specificity.
The linear regression equation, correlation coefficient
and LLOQ for typhaneoside, vanillic acid and p-
coumaric acid in rat plasma samples are shown in
Additional file 1. The calibration curves exhibited good
linearity with correlation coefficients (r) and the LLOQ
were sufficient for pharmacokinetic studies of these
analytes.
Intra-day, inter-day accuracy and precision of the three
compounds in rat plasma samples are presented in
Additional file 2, which showed the method with good
accuracy and precision. All the results were found to be
within the accepted variable limits.
Extraction recoveries and matrix effect of the three
compounds were evaluated by analyzing QC samples at
low, medium and high concentrations with six replicates.
As the results are shown in Additional file 3, the mean
recovery of the analytes was within 70 to 91 % (RSD was
less than 11). The corresponding matrix effect ranged
from 76 to 106 % (RSD was less than 9).
The stability of the analytes in rat plasma samples was
evaluated under different conditions. Deviations for the
peak area of the three components were within 15 %,
which indicated good stability under the experimental
conditions.
Pharmacokinetic study
The mean plasma concentration-time profiles of typhaneo-
side, vanillic acid and p-coumaric acid were determined
after oral administration with different compatibility of
Typhae Pollen-Trogopterus Feces drug pair in rats, the
concentration-time curves are presents in Fig. 3, and the
noncompartment model pharmacokinetic parameters
including maximum plasma concentration (Cmax), time to
reach the maximum concentrations (Tmax), half-time
(T1/2), area under concentration-time curve (AUC 0~t) are
summarized in Table 2.
From the datas, it indicated that typhaneoside, vanillic
acid and p-coumaric acid could be detected immediately
by UPLC-TQ/MS, which revealed superior absorption of
the three compounds, and significant differences existed
among three different compatibilities, all comparing to the
control group with TP single drug extraction by t-test. For
typhaneoside, the peak plasma concentration (Cmax) was
370.86 ± 315.71 ng/mL (P < 0.05) in TP-TF co-decoction
group (CM) and 214.32 ± 73.72 ng/mL (P < 0.01) in TP-TF
mixed decoction group (CB), it was significantly higher
than TP single drug extraction (CN), though in the previ-
ous report it was described as a low bioavailability [28].
What’s more, the time to reach maximum concentrations
(Tmax) were 0.24 ± 0.15 h (P < 0.05) for TP-TF co-
decoction group (CM) and 0.21 ± 0.08 h for TP-TF mixed
decoction group (CB), which implies highly uptake of this
compound in rats plasma.
As a kind of common compound in many Chinese
medicines, vanillic acid in TP-TF co-decoction group
(CM) had a good absorption after oral administration for
the Cmax was 3870.99 ± 2527.99 ng/mL and Tmax was
1.47 ± 3.20 h. In TP-TF mixed decoction group (CB) the
Table 2 Noncompartment model pharmacokinetic parameters of the three compounds after oral administration with extracts (n = 6)
Compounds Pharmacokinetic parameters TP TP-TF co-decoction TP-TF mixed decoction
Typhaneoside Cmax (ng/mL) 76.39 ± 53.21 370.86 ± 315.71
* 214.32 ± 73.72**
Tmax (h) 2.95 ± 2.88 0.24 ± 0.15
* 0.21 ± 0.08
T1/2 (h) 3.35 ± 2.58 1.91 ± 1.26 1.37 ± 0.54
AUC0~t (ng/h/mL) 268.31 ± 167.71 333.46 ± 191.84 275.62 ± 206.06
Vanillic acid Cmax (ng/mL) 2211.68 ± 1187.17 3870.99 ± 2527.99 1447.29 ± 500.99
Tmax (h) 1.25 ± 0.71 1.47 ± 3.20 0.17 ± 0.09
**
T1/2 (h) 3.69 ± 0.87 11.25 ± 13.61 8.88 ± 3.76
AUC0~t (ng/h/mL) 10445.53 ± 4148.68 14137.57 ± 4540.37 6193.78 ± 4499.17
P-coumaric acid Cmax (ng/mL) 4901.39 ± 1887.30 5110.22 ± 3671.26 4189.45 ± 844.37
Tmax (h) 1.08 ± 1.67 1.42 ± 1.39 0.46 ± 0.40
T1/2 (h) 3.67 ± 1.82 10.08 ± 7.86 10.08 ± 10.23
AUC0~t (ng/h/mL) 36881.01 ± 25783.25 41512.56 ± 41763.28 17689.11 ± 3882.21
*P < 0.05,** P < 0.01versus TP sole administration
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Cmax was 1447.29 ± 500.99 ng/mL and Tmax 0.17 ±
0.09 h (P < 0.01). In addition, it is not difficult to find
that Tmax and T1/2 in co-decoction group (CM) were lon-
ger than the two others, and double peak phenomenon
was observed at the same time, it probably attribute to
the enterohepatic circulation in drug metabolism or the
interactivity in Typhae pollen-Trogopterus Feces drug
pair. Similarly as vanillic acid, p-coumaric acid was also
absorbed well, Cmax was 5110.22 ± 3671.26 ng/mL in
TP-TF co-decoction group (CM) in addition to its Tmax
was somewhat longer. It may be in virtue of its hydro-
lyzed diffusion in vivo after oral administration with de-
coction [29], and we can see double peaks clearly on the
concentration-time curves, all these hypothesis need fur-
ther investigations.
When making comparison between TP-TF co-
decoction group (CM) and TP-TF mixed decoction
group (CB), Cmax and AUC0~t of the three active ingredi-
ents in TP-TF co-decoction group (CM) are higher than
TP-TF mixed decoction group (CB). It proved that the
absorption was increased after compatibility and the
duration of drug action was prolonged for T1/2 of the
three compounds in TP-TF co-decoction group (CM)
were longer than TP-TF mixed decoction group (CB).
Generally speaking, the TP-TF co-decoction group (CM)
showed more advantages of bioavailability for bioactive
components.
The results indicated that after Typhae Pollen and
Trogopterus Feces used in combination as a drug pair,
the three bioactive compounds typhaneoside, vanillic
acid and p-coumaric acid were well absorbed and slowly
eliminated in rats, thus to enhance and prolong clinical
efficacy, which may be due to the synergic action be-
tween Typhae Pollen and Trogopterus Feces. According
to traditional Chinese medicine theory, the compatibility
mechanisms of drug pairs are not only arbitrary plus of
two drugs but also the regularity of active components
in vivo [30]. When Typhae Pollen combined with Tro-
gopterus Feces, the dissolution of chemical ingredients
were increased [31], followed by the good absorption of
three components in TP. We speculated that it’s prob-
ably the volatile components in TF which enhanced the
absorption of the three components in TP [32, 33]. Fur-
thermore the higher uptake and slower elimination of
three compounds in TP by drug pair administration
were related to the interaction between drugs mediated
by transport proteins, metabolic enzymes, or plasma
protein binding, etc. The compatibility mechanism of
TP-TF still deserves further research.
Conclusion
In this paper, the simple, rapid and sensitive UPLC-TQ/MS
method was successfully applied to detect three bioactive
components in Typhae Pollen before and after the
combination with Trogopterus Feces simultaneously. It was
the first study to report about the pharmacokinetic parame-
ters of typhaneoside, vanillic acid and p-coumaric acid in
TP-TF after oral administration. Results indicated that the
three compounds have better absorption and slower elimin-
ation after Typhae Pollen and Trogopterus Feces combin-
ation. The in vivo changes of three main active substances
was helpful for finding the compatibility principles of TP-
TF and clarifying its rational compatibility, thus for better
clinical application and research about relative TCM
formulas.
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